Atomistry » Bromine » PDB 7oz7-7r3g » 7r0n
Atomistry »
  Bromine »
    PDB 7oz7-7r3g »
      7r0n »

Bromine in PDB 7r0n: KRASG12C in Complex with Gdp and Compound 2

Protein crystallography data

The structure of KRASG12C in Complex with Gdp and Compound 2, PDB code: 7r0n was solved by N.Ostermann, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 23.50 / 1.20
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 41.351, 59.228, 65.207, 90, 90, 90
R / Rfree (%) 20.2 / 22.2

Other elements in 7r0n:

The structure of KRASG12C in Complex with Gdp and Compound 2 also contains other interesting chemical elements:

Magnesium (Mg) 1 atom

Bromine Binding Sites:

The binding sites of Bromine atom in the KRASG12C in Complex with Gdp and Compound 2 (pdb code 7r0n). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the KRASG12C in Complex with Gdp and Compound 2, PDB code: 7r0n:

Bromine binding site 1 out of 1 in 7r0n

Go back to Bromine Binding Sites List in 7r0n
Bromine binding site 1 out of 1 in the KRASG12C in Complex with Gdp and Compound 2


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of KRASG12C in Complex with Gdp and Compound 2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br1002

b:39.4
occ:1.00
BR1 A:H401002 0.0 39.4 1.0
C5 A:H401002 1.8 30.8 1.0
N6 A:H401002 2.7 27.6 1.0
C4 A:H401002 2.9 25.9 1.0
O A:GLU62 3.0 23.1 1.0
C A:GLU62 3.0 21.1 1.0
O A:HOH1141 3.4 27.9 1.0
CA A:GLU62 3.4 20.0 1.0
CB A:GLU62 3.5 21.3 1.0
N A:GLU63 3.6 19.5 1.0
O A:HOH1251 3.7 29.4 1.0
OE1 A:GLN99 3.9 28.8 1.0
C1 A:H401002 4.0 24.5 1.0
C3 A:H401002 4.2 21.6 1.0
CA A:GLU63 4.2 18.5 1.0
C A:GLU63 4.4 17.2 1.0
CG A:GLU62 4.4 22.9 1.0
O A:GLU63 4.4 17.5 1.0
NH1 A:ARG68 4.5 15.2 1.0
C2 A:H401002 4.6 22.5 1.0
OE1 A:GLU62 4.8 26.5 1.0
N A:GLU62 4.8 19.3 1.0
N14 A:H401002 4.9 23.5 1.0
CD A:GLN99 4.9 25.2 1.0

Reference:

A.Weiss, E.Lorthiois, L.Barys, K.S.Beyer, C.Bomio-Confaglia, H.Burks, X.Chen, X.Cui, R.De Kanter, L.Dharmarajan, C.Fedele, M.Gerspacher, D.A.Guthy, V.Head, A.Jaeger, E.J.Nunez, J.D.Kearns, C.Leblanc, S.M.Maira, J.Murphy, H.Oakman, N.Ostermann, J.Ottl, P.Rigollier, D.Roman, C.Schnell, R.Sedrani, T.Shimizu, R.Stringer, A.Vaupel, H.Voshol, P.Wessels, T.Widmer, R.Wilcken, K.Xu, F.Zecri, A.F.Farago, S.Cotesta, S.M.Brachmann. Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, A Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C. Cancer Discov V. 12 1500 2022.
ISSN: ESSN 2159-8290
PubMed: 35404998
DOI: 10.1158/2159-8290.CD-22-0158
Page generated: Thu Jul 11 04:28:59 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy